All Stories

  1. Long Pentraxin 3 as a Broader Biomarker for Multiple Risk Factors in End-Stage Renal Disease: Association with All-Cause Mortality

    Article • Mediators of Inflammation, June 2019, Hindawi Publishing Corporation

    Alice Santos-Silva, Professor Elsa Bronze-da-Rocha

  2. The Protective Role of Adiponectin for Lipoproteins in End-Stage Renal Disease Patients: Relationship with Diabetes and Body Mass Index

    Article • Oxidative Medicine and Cellular Longevity, February 2019, Hindawi Publishing Corporation

    Alice Santos-Silva, Professor Elsa Bronze-da-Rocha, Vasco Miranda

  3. Hepcidin and diabetes are independently related with soluble transferrin receptor levels in chronic dialysis patients

    Article • Renal Failure, January 2019, Taylor & Francis

    Alice Santos-Silva

  4. Renal risk-benefit determinants of recombinant human erythropoietin therapy in the remnant kidney rat model - hypertension, anaemia, inflammation and drug dose

    Article • Clinical and Experimental Pharmacology and Physiology, February 2016, Wiley

    Alice Santos-Silva

  5. Brodalumab: an evidence-based review of its potential in the treatment of moderate-to-severe psoriasis

    Article • Core Evidence, July 2014, Taylor & Francis

    Professor Américo Figueiredo, Alice Santos-Silva